Catalyst Pharmaceuticals (CPRX) stock
NASDAQ
- Market cap
- Not available
- Date not confirmed
- P/E
- Not available
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- Not available
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
The price date behind the multiples is not confirmed; they may differ from the current price.
- Market cap
- Not available
- Date not confirmed
- P/E
- Not available
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- Not available
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
The price date behind the multiples is not confirmed; they may differ from the current price.
Latest earnings
SEC filingsJan–Mar 2026(FY2026 Q1)
Revenue increased 5.7% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $141M+5.7%
—
Jan–Mar '24
$141M
Jan–Mar '25
$149M
Jan–Mar '26
Blank bars mark quarters with no figure found in the filings.
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jan–Mar 2026 are from the 10-Q submitted to SEC EDGAR on May 11, 2026.
- Earnings per share increased 11.1% from the same quarter a year earlier.
- Revenue increased 5.7% from the same quarter a year earlier.
- Operating income increased 15.9% from the same quarter a year earlier.
- Net income increased 12.3% from the same quarter a year earlier.
Filed May 11, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Recent SEC filings
40 filingsFilings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Catalyst Pharmaceuticals (CPRX) stock information
NASDAQ
Catalyst Pharmaceuticals (CPRX) is listed on NASDAQ. These figures are computed in-house from official filings and are reference information only.
Catalyst Pharmaceuticals — frequently asked questions
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.